Pharmaceutical software company Veeva Systems has sued Microsoft in California federal court, alleging Microsoft's Viva ...

CENTRAL TRUST Co decreased its position in shares of Veeva Systems Inc. (NYSE:VEEV – Free Report) by 11.0% during the 4th ...

Veeva Systems (NYSE: VEEV) today announced that Servier will adopt Veeva RIM to unify its global regulatory operations. By ...

With Veeva RIM, Servier has a solution that enables quick adaptation to evolving EU regulatory demands. Veeva is partnering ...

DNAnexus, the leader in regulatory cloud services, today announced it will expand its relationship with Veeva to advance ...

Dan Rizzo, global head of Veeva Business Consulting, spoke with Pharmaceutical Executive about the state of product launches ...

Veeva Systems (VEEV) closed the most recent trading day at $233.29, moving +0.01% from the previous trading session.

Hantz Financial Services Inc. lessened its holdings in Veeva Systems Inc. (NYSE:VEEV – Free Report) by 64.8% during the 4th ...

In an interview with ACT senior editor Andy Studna at SCOPE Summit, Garty, chief technology officer, clinical data, provided his key takeaways from a panel he participated in on the growing interest ...

Leading biopharma to unify global regulatory operations on a single platform to speed submissions for new patient therapies BARCELONA, Spain, Feb. 4, 2025 /PRNewswire/ -- Veeva Systems ...

Wells Fargo analyst Stan Berenshteyn maintained a Hold rating on Doximity (DOCS – Research Report) yesterday and set a price target of $55.00.

Analysts fell to the sidelines weighing in on IQVIA Holdings (IQV – Research Report) and Doximity (DOCS – Research Report) with neutral ...